These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9597396)

  • 1. Is creatine supplementation helpful for patients with chronic heart failure?
    Schaufelberger M; Swedberg K
    Eur Heart J; 1998 Apr; 19(4):533-4. PubMed ID: 9597396
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of dietary creatine supplementation on skeletal muscle metabolism in congestive heart failure.
    Andrews R; Greenhaff P; Curtis S; Perry A; Cowley AJ
    Eur Heart J; 1998 Apr; 19(4):617-22. PubMed ID: 9597411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance.
    Gordon A; Hultman E; Kaijser L; Kristjansson S; Rolf CJ; Nyquist O; Sylvén C
    Cardiovasc Res; 1995 Sep; 30(3):413-8. PubMed ID: 7585833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early levosimendan administration may improve outcome in patients with subarachnoid hemorrhage complicated by acute heart failure.
    Papanikolaou J; Tsolaki V; Makris D; Zakynthinos E
    Int J Cardiol; 2014 Oct; 176(3):1435-7. PubMed ID: 25147072
    [No Abstract]   [Full Text] [Related]  

  • 5. [Calcium sensitizer agents in heart failure therapy].
    Iwama Y; Takagi A
    Nihon Rinsho; 2007 May; 65 Suppl 5():61-5. PubMed ID: 17571366
    [No Abstract]   [Full Text] [Related]  

  • 6. Amrinone: a promising new cardiotonic agent in the treatment of chronic cardiac failure.
    Likoff MJ; Weber KT; Andrews V; Janicki JS
    Herz; 1983 Aug; 8(4):199-205. PubMed ID: 6413341
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical use of inotropic therapy for heart failure: looking backward or forward? Part I: inotropic infusions during hospitalization.
    Stevenson LW
    Circulation; 2003 Jul; 108(3):367-72. PubMed ID: 12876135
    [No Abstract]   [Full Text] [Related]  

  • 8. [Progress in therapy for chronic heart failure].
    Hori M
    Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():111-5. PubMed ID: 11989248
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy and problems of cardiotonic agents viewed from physiopathology of chronic congestive heart failure].
    Asanoi H; Inoue H
    Nihon Naika Gakkai Zasshi; 1995 Sep; 84(9):1465-9. PubMed ID: 8537751
    [No Abstract]   [Full Text] [Related]  

  • 10. Patients with advanced heart failure and the effects of levosimendan.
    Song ZZ; Ma J
    Am J Cardiol; 2007 Aug; 100(4):742; author reply 742-3. PubMed ID: 17697841
    [No Abstract]   [Full Text] [Related]  

  • 11. Vesnarinone for heart failure.
    Schwartz A; Grupp I; Grupp G
    N Engl J Med; 1994 Jan; 330(1):65; author reply 66. PubMed ID: 8259153
    [No Abstract]   [Full Text] [Related]  

  • 12. [Heart failure].
    Erdmann E
    Internist (Berl); 1991 Apr; 32(4):W25-36. PubMed ID: 1856058
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the preoperative vasoactive-inotropic score as a predictor of postoperative outcomes in patients undergoing heart transplantation.
    Barge-Caballero E; Segovia-Cubero J; González-Vilchez F; Delgado-Jiménez J; Pérez-Villa F; Almenar-Bonet L; Arizón-Del Prado JL; Lage-Gallé E; De La Fuente-Galán L; Manito-Lorite N; Sanz-Julve M; Villa-Arranz A; Lambert Rodríguez JL; Brossa-Loidi V; Pascual-Figal D; Muñiz-García J; Crespo-Leiro M
    Int J Cardiol; 2015 Apr; 185():192-4. PubMed ID: 25797676
    [No Abstract]   [Full Text] [Related]  

  • 14. When should we use nitrates in congestive heart failure?
    Vizzardi E; Bonadei I; Rovetta R; D'Aloia A; Quinzani F; Curnis A; Dei Cas L
    Cardiovasc Ther; 2013 Feb; 31(1):27-31. PubMed ID: 22953723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creatine supplementation improves muscle strength in patients with congestive heart failure.
    Kuethe F; Krack A; Richartz BM; Figulla HR
    Pharmazie; 2006 Mar; 61(3):218-22. PubMed ID: 16599263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Digitalis: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects].
    Ashizawa N; Yano K
    Nihon Rinsho; 2007 May; 65 Suppl 5():14-8. PubMed ID: 17569306
    [No Abstract]   [Full Text] [Related]  

  • 17. Medical management of heart failure secondary to coronary artery disease.
    Challapalli S; Bonow RO; Gheorghiade M
    Coron Artery Dis; 1998; 9(10):659-74. PubMed ID: 9894618
    [No Abstract]   [Full Text] [Related]  

  • 18. [Calcium sensitizers--a new group of drugs that increase myocardium contractility].
    Laine M; Lehtonen L; Nieminen MS
    Duodecim; 2000; 116(20):2181-3. PubMed ID: 12017622
    [No Abstract]   [Full Text] [Related]  

  • 19. [Consensus of experts on the role of ethyl esters of omega-3 polyunsaturated fatty acids for the treatment and prevention of chronic heart failure (conclusion of experts meeting, June 2011)].
    Belenkov IuN; Mareev VIu; Arutiunov GP; Shliakhto EV; Koziolova NA; Ageev FT; Tatarskiĭ BA; Lopatin IuM; Fomin IV; Kastanian AA; Ardashev AV; Giliarevskiĭ SR; Moiseev SV; Doshitsin VL; Linchak RM;
    Kardiologiia; 2011; 51(9):89-91. PubMed ID: 21943014
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of a new positive inotropic agent on heart failure of a cardiopulmonary preparation].
    Kabela E; Michaels DC; Felice EL
    Arch Inst Cardiol Mex; 1979; 49(5):892-907. PubMed ID: 398199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.